Neovision Capital

Neovision Capital, established in 2015 and headquartered in Shanghai, China, is an investment firm focused on venture capital investments in early and growth-stage companies. The firm's founders bring a wealth of experience from prominent financial institutions, including Costone Capital and J.P. Morgan. Neovision Capital targets sectors such as healthcare, information technology, telecommunications, media, and technology. The company leverages its team's extensive operational experience in China, along with international resources, to provide strategic support to its portfolio companies. This includes expertise in areas such as branding, marketing, channel development, overseas expansion, human resources, and finance. Neovision Capital also maintains a presence in Nanjing, enhancing its ability to identify and nurture promising ventures within its preferred industries.

Mingxing He

Executive Managing Director

Liu Chuanwen

Managing Director

Qin CFA, Yangwen

Managing Partner

Qin Yangwen

Managing Partner

Past deals in Cayman Islands

Xgene Pharmaceutical

Series C in 2021
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.